您要查找的是不是：
- There is a acellular pertussis vaccine. 无细胞百日咳疫苗。
- tetanus, diphtheria & pertussis vaccine 破伤风、白喉和百日咳疫苗<生物制品>
- TPer/Vac(tetanus and pertussis vaccine) 破伤风和百日咳疫苗[生物制剂]
- Diphtheria Tetanus Pertussis and Poliomyeli-tis Vaccine 白喉-破伤风-百日咳-脊髓灰质炎菌苗[生物制剂]
- Pertussis vaccines -- are they safe and effective? 百日咳菌苗-它们是安全与有效的?
- diphtheria and tetanus toxoids and pertussis vaccine 白喉、破伤风类毒素、百日咳菌苗混合制剂, 百白破三联制剂
- adsorbed diphtheria and tetanus toxoids and pertussis vaccine 吸附白喉、破伤风类毒素, 百日咳菌苗混合制剂, 吸附百白破三联制剂
- adsorbed diphtheria, tetanus toxoid and pertussis vaccine 吸附白喉; 破伤风类毒素和百日咳菌苗混合制剂
- diphtheria and tetanus toxoids and pertussis vaccine, adsorbed 吸附白喉百日咳破伤风三联菌苗, 吸附白百破三联菌苗
- The infant receives three injections of pertussis vaccine at one-month intervals. 婴儿以一个月为间隔，接受三次百日咳疫苗的注射。
- Conclusion The developed quality control method was suitable for the acellular pertussis vaccine in China. 结论所建立的质量控制方法可用于我国无细胞百日咳疫苗的质量控制。
- Most infants receive a pertussis vaccine, but its effectiveness subsides after about 10 years. 大多数婴儿会接受百日咳疫苗的接种，但是在十年后效果会降低。
- The acellular pertussis vaccine manufactured by Lanzhou Institute of Biological Products was investigated for purity、toxicity and potency. 本文对无细胞百日咳菌苗的纯度、免疫力和毒性进行了研究。
- Acellular pertussis vaccine recommended by WHO should contain five components: PT, FHA, PRN, FIM2 and FIM3, the major component is PT. FIM2和FIM3是百日咳杆菌的3种保护性抗原，在百日咳杆菌的致病和免疫过程中起重要作用。
- Objective In order to select the best preparation procedure of the national reference on toxicity of acellular pertussis vaccine. 目的筛选无细胞百日咳疫苗毒性国家参考品的最佳生产工艺。
- Objective To develop the methods for determination of component content and purity of acellular pertussis vaccine in China. 摘要目的建立我国无细胞百日咳疫苗组分含量和纯度的检测方法。
- Methods A mouse s point Houhai, point Zhongwan or abdominal cavity was injected with pertussis vaccine and its immune response was observed. 方法对小白鼠后海穴、中脘穴、腹腔注射百日咳疫苗观察其免疫力。
- Bordetella pertussis toxin S1 mutant was successfully expressed and purified,which laid a molecular immunological foundation of developing candidate antigen of pertussis vaccine. 成功表达并纯化了百日咳毒素S1亚单位突变体,为研制百日咳疫苗候补抗原的相关分子免疫学研究奠定了基础。
- absorbed diphtheria, tetanus and pertussis vaccines 吸附百日咳菌苗; 白喉和破伤风类毒素混合制剂
- alum precipitated pertussis vaccine [医] 明矾沉淀百日咳菌苗
